Logo image of BKYI

BIO-KEY INTERNATIONAL INC (BKYI) Stock Fundamental Analysis

NASDAQ:BKYI - Nasdaq - US09060C5076 - Common Stock - Currency: USD

0.7526  -0.01 (-0.96%)

After market: 0.7425 -0.01 (-1.34%)

Fundamental Rating

2

BKYI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 283 industry peers in the Software industry. BKYI has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, BKYI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BKYI has reported negative net income.
In the past year BKYI has reported a negative cash flow from operations.
BKYI had negative earnings in each of the past 5 years.
In the past 5 years BKYI always reported negative operating cash flow.
BKYI Yearly Net Income VS EBIT VS OCF VS FCFBKYI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

BKYI's Return On Assets of -41.18% is on the low side compared to the rest of the industry. BKYI is outperformed by 81.69% of its industry peers.
With a Return On Equity value of -60.16%, BKYI is not doing good in the industry: 70.77% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -41.18%
ROE -60.16%
ROIC N/A
ROA(3y)-114.47%
ROA(5y)-83.08%
ROE(3y)-380.85%
ROE(5y)-244.63%
ROIC(3y)N/A
ROIC(5y)N/A
BKYI Yearly ROA, ROE, ROICBKYI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

The Gross Margin of BKYI (80.03%) is better than 80.63% of its industry peers.
In the last couple of years the Gross Margin of BKYI has grown nicely.
BKYI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 80.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.53%
GM growth 5YN/A
BKYI Yearly Profit, Operating, Gross MarginsBKYI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

2

2. Health

2.1 Basic Checks

BKYI does not have a ROIC to compare to the WACC, probably because it is not profitable.
BKYI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BKYI has more shares outstanding
Compared to 1 year ago, BKYI has a worse debt to assets ratio.
BKYI Yearly Shares OutstandingBKYI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
BKYI Yearly Total Debt VS Total AssetsBKYI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

BKYI has an Altman-Z score of -16.24. This is a bad value and indicates that BKYI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BKYI (-16.24) is worse than 91.55% of its industry peers.
BKYI has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of BKYI (0.10) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z -16.24
ROIC/WACCN/A
WACC11.98%
BKYI Yearly LT Debt VS Equity VS FCFBKYI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 1.32 indicates that BKYI should not have too much problems paying its short term obligations.
BKYI has a Current ratio of 1.32. This is comparable to the rest of the industry: BKYI outperforms 41.90% of its industry peers.
A Quick Ratio of 1.22 indicates that BKYI should not have too much problems paying its short term obligations.
The Quick ratio of BKYI (1.22) is worse than 62.68% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 1.22
BKYI Yearly Current Assets VS Current LiabilitesBKYI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 80.30% over the past year.
BKYI shows a decrease in Revenue. In the last year, the revenue decreased by -7.26%.
Measured over the past years, BKYI shows a very strong growth in Revenue. The Revenue has been growing by 25.01% on average per year.
EPS 1Y (TTM)80.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)-7.26%
Revenue growth 3Y10.69%
Revenue growth 5Y25.01%
Sales Q2Q%-26.32%

3.2 Future

BKYI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.00% yearly.
The Revenue is expected to grow by 7.75% on average over the next years.
EPS Next Y70.43%
EPS Next 2Y34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.83%
Revenue Next 2Y7.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BKYI Yearly Revenue VS EstimatesBKYI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
BKYI Yearly EPS VS EstimatesBKYI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -20 -40 -60 -80 -100

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BKYI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BKYI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BKYI Price Earnings VS Forward Price EarningsBKYI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BKYI Per share dataBKYI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as BKYI's earnings are expected to grow with 34.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BKYI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BIO-KEY INTERNATIONAL INC

NASDAQ:BKYI (8/8/2025, 8:21:09 PM)

After market: 0.7425 -0.01 (-1.34%)

0.7526

-0.01 (-0.96%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-19 2025-05-19
Earnings (Next)08-12 2025-08-12
Inst Owners7.67%
Inst Owner Change2.64%
Ins Owners3.61%
Ins Owner Change1.75%
Market Cap5.16M
Analysts82.86
Price Target2.04 (171.06%)
Short Float %2.23%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)64.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.81
P/FCF N/A
P/OCF N/A
P/B 0.7
P/tB 0.82
EV/EBITDA N/A
EPS(TTM)-2
EYN/A
EPS(NY)-0.39
Fwd EYN/A
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.59
OCFYN/A
SpS0.93
BVpS1.07
TBVpS0.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -41.18%
ROE -60.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 80.03%
FCFM N/A
ROA(3y)-114.47%
ROA(5y)-83.08%
ROE(3y)-380.85%
ROE(5y)-244.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.53%
GM growth 5YN/A
F-Score5
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.11%
Cap/Sales 0.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 1.22
Altman-Z -16.24
F-Score5
WACC11.98%
ROIC/WACCN/A
Cap/Depr(3y)7.54%
Cap/Depr(5y)11.19%
Cap/Sales(3y)0.43%
Cap/Sales(5y)0.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y70.43%
EPS Next 2Y34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.26%
Revenue growth 3Y10.69%
Revenue growth 5Y25.01%
Sales Q2Q%-26.32%
Revenue Next Year-5.83%
Revenue Next 2Y7.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y40.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y39.82%
OCF growth 3YN/A
OCF growth 5YN/A